Due Diligence Call with Endometrics

A due diligence call is scheduled with Endometrics (22-May Regular Pitch Event) on Thursday, 30-May-2024 at 12pm PT // 3pm ET.

Please submit due diligence questions for Endometrics: Endometrics_DD_Pitch Follow-up Questions_22-May-2024

Joining information will be sent upon registration.

  Endometrics develops a novel non-invasive diagnostic tests for women using menstrual blood.

PROBLEM: Millions of women face unexplained infertility, while in reality, it's not unexplained - it’s unexplored. 1 in 10 women is affected by endometriosis, > 70% are repeatedly misdiagnosed, and the diagnostic delay is 8 years. Endometriosis is a leading cause of infertility and IVF failures, yet surgery remains the only available option for diagnosis.

SOLUTION: Endometrics develops a unique solution for the non-invasive diagnosis of endometriosis using menstrual blood. No more unnecessary appointments, no more invasive procedures, no more IVF failures, no more wasting time in pain.

SOURCED BY MEMBER, JULIE LAWRENCE

DEAL LEAD: Looking for volunteers

RECORDING OF 22-MAY PITCH PRESENTATION

DEALUM

SLACK

PITCH DECK

TERMS: 1.5M, SAFE, 15M post-money (flexible and open to discussing the terms with interested investors)

SUBMIT DD QUESTIONS